Authorization

Osmotica Pharmaceuticals plc to Provide Second Quarter 2020 Business and Financial Update and Presentation on Upneeqa?? on August 11, 2020

BRIDGEWATER, N.J., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (a??Osmoticaa?? or the a??Companya??), a fully integrated biopharmaceutical company, today announced that the Company will release its 2020 second quarter financial results on Tuesday, August 11, 2020, after the close of the U.S. financial markets.
Brian Markison, Chief Executive Officer, James a??JDa?? Schaub, Chief Operating Officer, and Andrew Einhorn, Chief Financial Officer, will host a conference call as follows: A 

Date











Tuesday, August 11, 2020



Time











4:30 p.m. ET



Toll free (U.S.)











(866) 672-5029



International











(409) 217-8312



Conference ID











5287688



Webcast (live and replay)











www.osmotica.com under the a??Investor & Newsa?? section

About Osmotica Pharmaceuticals plc
Osmotica Pharmaceuticals plcA is a fully integrated biopharmaceutical company focused on the development and commercialization of specialty products that target markets with underserved patient populations. The company has a diverse portfolio consisting of four promoted products and approximately 30 non-promoted products, several of which incorporate Osmoticaa??s proprietary OsmodexA®A drug delivery system.A RVL Pharmaceuticals, Inc.A is the Companya??s ophthalmic subsidiary supporting UPNEEQ.A Vertical Pharmaceuticals, LLCA represents the Companya??s diversified branded portfolio andA Trigen Laboratories, LLCA represents the Companya??s non-promoted products, including complex generic formulations.Osmotica has operations inA the United States,A Argentina, andA Hungary.
See also:
Leave a comment
News
  • Latest
  • Read
  • Commented
Calendar Content
«    Сентябрь 2020    »
ПнВтСрЧтПтСбВс
 123456
78910111213
14151617181920
21222324252627
282930